Cargando…
Empagliflozin induced euglycemic diabetic ketoacidosis. A case reports
INTRODUCTION: Diabetic ketoacidosis (DKA) is one of the most serious acute complications of diabetes. Its defining features are hyperglycemia and ketoacidosis. Euglycemic DKA (EDKA) affects patients whose serum glucose levels are within the normal range. The use of sodium-glucose cotransporter 2 (SG...
Autor principal: | Altowayan, Waleed M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793230/ https://www.ncbi.nlm.nih.gov/pubmed/36582864 http://dx.doi.org/10.1016/j.amsu.2022.104879 |
Ejemplares similares
-
Empagliflozin: Euglycemic and hyperglycaemic diabetic ketoacidosis: case report
Publicado: (2021) -
The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin
por: Candelario, Nellowe, et al.
Publicado: (2016) -
Euglycemic Diabetic Ketoacidosis in a Lung Cancer Patient Using Empagliflozin
por: Sexe, Jordan, et al.
Publicado: (2020) -
Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus
por: Albugami, Muneerah M., et al.
Publicado: (2020) -
Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis
por: Calçada, Marta Brandão, et al.
Publicado: (2021)